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Abstract
Background: Primary immunodeficiency is a life-threatening genetic disease that appeared to have an increased
incidence in Manitoba Mennonites. Determining the genetic basis of this immunodeficiency was an essential step
for providing early and appropriate medical intervention.
Methods: Initially, DNA from probands affected with primary immunodeficiency and their family members was
assessed for linkage to genes previously associated with immunodeficiency. Candidate genes were sequenced to
identify the causative mutation. The frequency of the mutation among first and second degree relatives, as well as
apparently unrelated community members was analyzed using a PCR-based assay.
Results: A previously described c.1624–11G>A mutation in ZAP70 was identified as the causative mutation in all
affected probands that were analyzed. Among 125 study participants of Mennonite descent, 79 genotyped as normal,
39 were carriers and seven were affected. None of 115 non-Mennonite random individuals carried the mutation,
whereas one of ten random DNA samples from individuals who self-identified as Mennonite was a carrier.
Conclusions: In collaboration with the target community, we have developed a robust screening test for determining
ZAP70 genotype. Early identification of affected individuals has provided an opportunity for timely clinical intervention,
while carrier identification has allowed for genetic counselling of at risk couples.
Background
Primary immune deficiencies comprise a broad spectrum
of diseases, ranging from severe combined immunodefi-
ciency syndrome (SCID) which is uniformly lethal without
a stem cell transplant, to several milder forms [1]. Among
these is an autosomal recessively inherited ZAP-70 (zeta-
chain associated protein kinase 70) deficiency, which des-
pite having a less severe clinical phenotype, typically results
in death by two years of age due to overwhelming sepsis.
Arpaia et al., [2] defined the underlying mutation in three
patients of Mennonite descent as a homozygous intronic
ZAP70 single nucleotide substitution (c.1624–11G>A). This
mutation creates a new acceptor splice site, resulting in the
insertion of nine nucleotides to the mRNA. The altered
protein product is unstable, leading to a complete loss of
kinase activity. Since ZAP-70 kinase is involved in T cell
receptor signaling and is critical for T cell maturation, loss
of function mutations lead to an absence of CD8+ T cells
and inactive CD4+ T cells [2–5].
Mennonites are Anabaptists who descended from
Swiss, Dutch and German ancestors. Persecuted for their
religious beliefs and pacifism, Mennonite communities
settled in various parts of Europe, seeking regions that
were either sympathetic to, or tolerant of, their way of
life. The first Mennonites (Swiss/German) immigrated to
North America in the late 18th century, settling primarily
in Southern Ontario and Pennsylvania [6]. The Dutch/
German Mennonites eventually settled in Russia and
then immigrated to the Canadian prairies in two major
waves, with about 7,000 immigrants arriving in the early
1870s, and another approximately 20,000 after World
War I (1922 - 1930) [7].
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For cultural and religious reasons Mennonites consti-
tute a genetic isolate, where founding alleles continue to
be expressed in the current population. We identified
the ZAP70 c.1624–11G>A mutation as the cause of a
primary immunodeficiency in an extended Mennonite
kindred. Prompted by the local Mennonite community
and because timely diagnosis and treatment [8] are
essential to reducing mortality due to ZAP-70 kinase
deficiency, we developed a screening test which identi-
fied the c.1624–11G>A mutation as a frequent cause of
immunodeficiency in this population.
Methods
Subjects
In total, 125 Mennonite subjects were enrolled in our
study. Initially all test subjects were first or second
degree relatives (105 individuals) of an affected indi-
vidual. As the results became available to the family
members, 20 other individuals of the broader commu-
nity volunteered samples for ZAP70 genotyping.
These included young married couples expecting their
first child, newly married couples (including two
spouses of successfully treated affected individuals)
and unmarried young adults. DNA from 125 random
individuals, 10 of whom self-reported as Mennonite,
was also used in this study.
Clinical Synopsis
All affected children were well at birth, and presented
between the ages of 4 and 17 months. Two were diagnosed
shortly after birth before they became unwell because of an
affected sibling. The method of presentation varied, how-
ever recurrent respiratory infection was seen in all of them.
Pneumocystis jirovecci pneumonia requiring ventilation
was the presenting symptom in one at the age of 4 months.
A generalized failure to thrive, skin rash, enteritis, feeding
difficulties, otitis media, thrush and pneumonia were seen
with variable severity in all. B- and T-lymphocytes were
present within the normal range in all patients, however
the CD8+ count was decreased in all. The absence of a
T-cell response to phytohemagglutinin was universal. Im-
mune function was reconstituted by hematopoietic stem
cell transplantation and all seven patients are currently alive
and well (3 to 24 years post-transplant).
Sanger Sequencing
Sanger sequencing was performed at The Centre for
Applied Genomics, (The Hospital for Sick Children,
Toronto, Canada), using the same primers and under
the same conditions as were used for genotyping. The
DNA sequence was determined for both strands of all
fragments. The sequences obtained were compared with
the reference allele sequence ZAP70 (GenBank Accession
number: NG_007727.1 for gDNA).
Fig. 1 Ancestral pedigree depicting the relationship between three affected individuals. The common ancestor for three individuals homozygous
(shaded symbols; designated with arrows) for the c.1624–11G>A mutation in ZAP70 is an individual who was born in 1816. Individuals heterozygous
for c.1624–11G>A are depicted as half-shaded circles and squares, and consanguineous marriages are depicted by double solid lines. Open circles in
the bottom generation represent individuals who do not carry the ZAP70 mutation. Not all individuals depicted were tested for the ZAP70 mutation
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c.1624–11G>A ZAP70 Genotyping
Genomic DNA isolated from whole or cord blood (50–
100 ng) or buccal swab (20–50 ng), was PCR amplified
for three min at 95 °C for one cycle, one min at 95 °C,
one min at 59 °C and 2 min at 72 °C for 30 cycles,
followed by 10 min at 72 °C for one cycle, using the
forward (5′-GTGATGCCCGACTGGATG-3′) and the re-
verse (5′-GGCTTTGGGTGAGATGACA-3′) primers. An
aliquot of the resulting 534 bp product was incubated at
37 °C for 3 hr with 10U AluI. Products were resolved on a
2 % agarose gel for 1 hr at 150 V. Each genotyping result
was determined by comparison, on the same gel, with
DNA from known normal, carrier and affected individuals.
Results
The recognition of an apparent increased frequency of im-
munodeficiency among Mennonite children in Manitoba
[9] provided the impetus to search for the cause of this
disorder in three affected individuals and their immediate
families (pedigree depicted in Fig. 1). Each of the affected
individuals depicted descend from a common ancestor,
born in 1816. Initially, microsatellite markers surrounding
genes known to cause primary immunodeficiency were
analyzed in these families. All three affected individuals
were identically homozygous for six markers flanking
ZAP70 (data not shown). Subsequently, Sanger sequen-
cing (Fig. 2a) of DNA from these three affected individuals
revealed that all were homozygous for the previously
defined [2] ZAP70 mutation (c.1624–11G>A). The
extended families of the other four affected individuals
from this study also display consanguinity loops (pedigrees
not shown), but a single ancestor common to all seven
affected individuals was not identified.
Because the causative mutation, c.1624–11G>A in
ZAP70 has been shown to cause protein deficiency
underscoring the phenotype [2–5], we developed a PCR-
based assay to determine the genotypes of related and
unrelated Mennonite individuals. The g to a intronic
mutation (Fig. 2b and c) creates an AluI site (ggct to
agct) that allows carriers, non-carriers and affected indi-
viduals to be readily differentiated (Fig. 2d). Genotyping
was conducted on genomic DNA isolated from whole or
cord blood, or buccal swab. All genotypes determined
from cord blood were confirmed with a peripheral blood
sample, as a way to exclude possible maternal contamin-
ation of the cord sample. In all cases genotypes of the
peripheral sample were concordant with those deter-
mined on the cord sample. Of the 125 study subjects, 79
typed as normal (GG), 39 as carriers (AG), and 7 as
affected (AA). In addition, we determined ZAP70 geno-
types for 115 random individuals, all of whom typed as
normal, and also from ten random individuals who self-
identified as of Mennonite descent, one of whom geno-
typed as a carrier.
Discussion
Because immune deficiencies in children should be
considered pediatric emergencies, early diagnosis and
treatment [8, 10] is the very best option for affected
individuals. However, recognizing immune deficiency
caused by a loss of function mutation in ZAP70 can be
difficult and even delayed because most patients have
detectable lymphoid tissue, normal lymphocyte counts
and immunoglobulin levels [9, 11, 12]. Additionally, the
age of presentation can vary from about 4–17 months,
and in the case of Mennonites, affected children living
Fig. 2 Analyzing the c.1624−11G>A mutation of ZAP70. Panel a - Sanger
sequencing of genomic DNA from an affected individual depicting
a homozygous intronic g >a mutation. Panel b – A schematic
representation of a portion of the ZAP70 gene indicating how the
mutation generates a new acceptor sequence in affected individuals.
Panel c – A restriction map of the PCR amplified product depicting
the position of a second AluI cutting site (↑) in mutated alleles. Panel
d - 534 bp PCR products were digested with AluI and the resulting
fragments separated by agarose gel electrophoresis. Lane 1 is a 100 bp
DNA standard and Lane 2 is a water blank (B). Lanes 3 through 12
depict fragments generated from individuals of normal (N) genotype
(370 bp and 164 bp), affected (A) genotype (230 bp, 164 bp and
140 bp) or carrier (C) genotype (370 bp, 230 bp, 164 bp and 140 bp)
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in rural communities may not be referred to the pediatric
tertiary care center in a timely manner.
Our study underscores the importance of developing a
targeted screening test for ZAP-70 kinase deficiency in
Mennonites and for engaging the community at the on-
set. All of our study subjects belong to the same genetic
isolate and can trace their roots to a group of immi-
grants arriving to Canada in the 1870s. Because of a high
birth rate and large family size, the founding c.1624–
11G>A allele of ZAP70 has been maintained in the
current population. Our identification of 39 carriers
among 125 study subjects is not surprising since most
participants were directly related to an affected individ-
ual, but the identification of a carrier in 10 random
Mennonite samples is concerning. We do acknowledge
that estimates of carrier allele prevalence using just 10
samples may not accurately reflect the true frequency,
but finding random samples for such calculations in a
closed population is impossible. Despite these limita-
tions, we have identified affected individuals in multiple
families, suggesting that the c.1624–11G>A allele of
ZAP70 is frequent enough in the Canadian Mennonite
community. Further, because members of this cohort have
moved to Mexico (including one of the families we stud-
ied with two affected children), Belize, Paraguay and other
South American countries, screening for the c.1624–
11G>A allele of ZAP70 should also be undertaken in these
countries.
Conclusion
The development of a definitive screening test for ZAP-
70 kinase deficiency in Mennonites will ensure prompt
diagnosis and treatment for affected children, and will
also provide pregnancy counselling opportunities for at
risk couples in Canada and around the world.
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